Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Schering/SEC settlement

This article was originally published in The Tan Sheet

Executive Summary

Schering-Plough agreement with the Securities & Exchange Commission involves payment of a $500,000 civil penalty in connection with the agency's investigation of compliance and accounting violations by a Polish subsidiary. The SEC issued a formal order in November 2003 to investigate the subsidiary's compliance with U.S. Foreign Corrupt Practices Act. The records and internal accounting control issues were related to discontinued charitable contributions, according to a June 9 release. "As we implement our Action Agenda to build a new company, one of the drivers of the transformation process is embedding business integrity into every area of the organization worldwide going forward," said Senior VP-Global Compliance & Business Practices Brent Saunders...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096942

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel